Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy

被引:50
|
作者
Chen, William C. [1 ]
Magill, Stephen T. [2 ]
Wu, Ashley [1 ]
Vasudevan, Harish N. [1 ]
Morin, Olivier [1 ]
Aghi, Manish K. [2 ]
Theodosopoulos, Philip V. [2 ]
Perry, Arie [2 ,3 ]
McDermott, Michael W. [2 ]
Sneed, Penny K. [1 ]
Braunstein, Steve E. [1 ]
Raleigh, David R. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA
关键词
atypical meningioma; MIB1; radiation; radiotherapy; oncology; CENTRAL-NERVOUS-SYSTEM; GROSS-TOTAL RESECTION; PROGNOSTIC-FACTORS; RADIATION-THERAPY; ANAPLASTIC MENINGIOMAS; SURGICAL RESECTION; UNITED-STATES; PRIMARY BRAIN; TUMORS; CLASSIFICATION;
D O I
10.3171/2017.9.JNS171609
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE The goal of this study was to investigate the impact of adjuvant radiotherapy (RT) on local recurrence and overall survival in patients undergoing primary resection of atypical meningioma, and to identify predictive factors to inform patient selection for adjuvant RT. METHODS One hundred eighty-two patients who underwent primary resection of atypical meningioma at a single institution between 1993 and 2014 were retrospectively identified. Patient, meningioma, and treatment data were extracted from the medical record and compared using the Kaplan-Meier method, log-rank tests, multivariate analysis (MVA) Cox proportional hazards models with relative risk (RR), and recursive partitioning analysis. RESULTS The median patient age and imaging follow-up were 57 years (interquartile range [IQR] 45-67 years) and 4.4 years (IQR 1.8-7.5 years), respectively. Gross-total resection (GTR) was achieved in 114 cases (63%), and 42 patients (23%) received adjuvant RT. On MVA, prognostic factors for death from any cause included GTR (RR 0.4, 95% CI 0.1-0.9, p = 0.02) and MIB1 labeling index (LI) <= 7% (RR 0.4, 95% CI 0.1-0.9, p = 0.04). Prognostic factors on MVA for local progression included GTR (RR 0.2, 95% CI 0.1-0.5, p = 0.002), adjuvant RT (RR 0.2, 95% CI 0.1-0.4, p < 0.001), MIB1 LI <= 7% (RR 0.2, 95% CI 0.1-0.5, p < 0.001), and a remote history of prior cranial RT (RR 5.7, 95% CI 1.3-18.8, p = 0.03). After GTR, adjuvant RT (0 of 10 meningiomas recurred, p = 0.01) and MIB1 LI <= 7% (RR 0.1, 95% CI 0.003-0.3, p < 0.001) were predictive for local progression on MVA. After GTR, 2.2% of meningiomas with MIB1 LI <= 7% recurred (1 of 45), compared with 38% with MIB1 LI > 7% (13 of 34; p < 0.001). Recursive partitioning analysis confirmed the existence of a cohort of patients at high risk of local progression after GTR without adjuvant RT, with MIB1 LI > 7%, and evidence of brain or bone invasion. After subtotal resection, adjuvant RT (RR 0.2, 95% CI 0.04-0.7, p = 0.009) and <= 5 mitoses per 10 hpf (RR 0.1, 95% CI 0.03-0.4, p = 0.002) were predictive on MVA for local progression. CONCLUSIONS Adjuvant RT improves local control of atypical meningioma irrespective of extent of resection. Although independent validation is required, the authors' results suggest that MIB1 LI, the number of mitoses per 10 hpf, and brain or bone invasion may be useful guides to the selection of patients who are most likely to benefit from adjuvant RT after resection of atypical meningioma.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 50 条
  • [21] Histopathological features to define atypical meningioma: What does really matter for prognosis?
    Valeria Barresi
    Simona Lionti
    Samuel Caliri
    Maria Caffo
    Brain Tumor Pathology, 2018, 35 : 168 - 180
  • [22] Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
    Hemmati, Saman Moritz
    Ghadjar, Pirus
    Gruen, Arne
    Badakhshi, Harun
    Zschaeck, Sebastian
    Senger, Carolin
    Acker, Gueliz
    Misch, Martin
    Budach, Volker
    Kaul, David
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [23] The Impact Of Adjuvant Radiotherapy On Atypical Meningioma Recurrence Following Aggressive Microsurgical Resection
    Hardesty, Douglas
    Wolf, Andrew
    Brachman, David
    McBride, Heyoung
    Youssef, Emad
    Nakaji, Peter
    Porter, Randall
    Smith, Kris
    Spetzler, Robert
    Sanai, Nader
    JOURNAL OF NEUROSURGERY, 2013, 119 (02) : A578 - A578
  • [24] Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
    Saman Moritz Hemmati
    Pirus Ghadjar
    Arne Grün
    Harun Badakhshi
    Sebastian Zschaeck
    Carolin Senger
    Güliz Acker
    Martin Misch
    Volker Budach
    David Kaul
    Radiation Oncology, 14
  • [25] Histopathological features to define atypical meningioma: What does really matter for prognosis?
    Barresi, Valeria
    Lionti, Simona
    Caliri, Samuel
    Caffo, Maria
    BRAIN TUMOR PATHOLOGY, 2018, 35 (03) : 168 - 180
  • [26] Radiotherapy after surgery for benign cerebral meningioma
    Soyuer, S
    Chang, EL
    Selek, U
    Shi, WM
    Maor, MH
    DeMonte, F
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 (01) : 85 - 90
  • [27] Prognostic factors affecting overall survival and local control in meningioma patients treated with radiotherapy or combined radiotherapy and surgery
    Silva, Scott R.
    Sethi, Anil
    Prabhu, Vikram C.
    Anderson, Douglas
    Melian, Edward
    JOURNAL OF RADIATION ONCOLOGY, 2018, 7 (01) : 27 - 35
  • [28] Dose–response relationship in patients with newly diagnosed atypical meningioma treated with adjuvant radiotherapy
    Dowook Kim
    Won Ick Chang
    Hwa Kyung Byun
    In Ah Kim
    Jaeho Cho
    Joo Ho Lee
    Hong In Yoon
    Chan Woo Wee
    Journal of Neuro-Oncology, 2023, 161 : 329 - 337
  • [29] Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma
    Aizer, Ayal A.
    Arvold, Nils D.
    Catalano, Paul
    Claus, Elizabeth B.
    Golby, Alexandra J.
    Johnson, Mark D.
    Al-Mefty, Ossama
    Wen, Patrick Y.
    Reardon, David A.
    Lee, Eudocia Q.
    Nayak, Lakshmi
    Rinne, Mikael L.
    Beroukhim, Rameen
    Weiss, Stephanie E.
    Ramkissoon, Shakti H.
    Abedalthagafi, Malak
    Santagata, Sandro
    Dunn, Ian F.
    Alexander, Brian M.
    NEURO-ONCOLOGY, 2014, 16 (11) : 1547 - 1553
  • [30] Adjuvant Radiotherapy VersusWatchfulWaiting for WHO Grade II Atypical Meningioma: A Single Institution Experience
    Bray, David
    Quillin, Joseph
    Press, Robert
    Yang, Yilin
    Wu, Jiayi
    Chen, Zhengjia
    Eaton, Bree
    Olson, Jeffrey J.
    NEUROSURGERY, 2020, 67 : 296 - 296